Floatz logo

Allogeneic Mesenchymal Stem Cells

Wilson's Disease

Murat KantarciogluCell therapyN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Wilson's Disease cohort.

Asset / SponsorPhaseRating
ZINC ACETATE
Nobelpharma
Phase 4BBB
Teta 4Hcl
Orphalan
Phase 3BBB
ZINC D-GLUCONATE (1:2)
Jun Li
Phase 4BBB
Trientine
Excelsior
Phase 3BB
Penicillamine
Orphalan
Phase 3BB

View all 21 →

Same molecule, other indications

Allogeneic Mesenchymal Stem Cells is also rated in:

alcoholic liver cirrhosisDormant
B
Indicative ·
57 / 100
View asset →
ischemic strokeDormant
CCC
Indicative ·
51 / 100
View asset →
stroke disorderDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →